pubmed-article:16772930 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16772930 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
pubmed-article:16772930 | lifeskim:mentions | umls-concept:C0006434 | lld:lifeskim |
pubmed-article:16772930 | lifeskim:mentions | umls-concept:C0043250 | lld:lifeskim |
pubmed-article:16772930 | lifeskim:mentions | umls-concept:C0033809 | lld:lifeskim |
pubmed-article:16772930 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
pubmed-article:16772930 | lifeskim:mentions | umls-concept:C0016194 | lld:lifeskim |
pubmed-article:16772930 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:16772930 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
pubmed-article:16772930 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
pubmed-article:16772930 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:16772930 | pubmed:dateCreated | 2006-6-14 | lld:pubmed |
pubmed-article:16772930 | pubmed:abstractText | In an era of increasing drug resistance, immunotherapy is a desirable treatment against Pseudomonas aeruginosa infections. The flagellum, which is an important pseudomonal virulence factor, was targeted for immunotherapy. The aim of the study was to evaluate the efficacy of polyclonal immunotherapy targeted against the N-terminal of flagellin (anti-N'-fla-b) for treating severe P. aeruginosa infection in a murine burn wound model. | lld:pubmed |
pubmed-article:16772930 | pubmed:language | eng | lld:pubmed |
pubmed-article:16772930 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16772930 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16772930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16772930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16772930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16772930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16772930 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16772930 | pubmed:month | Jun | lld:pubmed |
pubmed-article:16772930 | pubmed:issn | 1529-4242 | lld:pubmed |
pubmed-article:16772930 | pubmed:author | pubmed-author:CarmeliYehuda... | lld:pubmed |
pubmed-article:16772930 | pubmed:author | pubmed-author:ErenRachelR | lld:pubmed |
pubmed-article:16772930 | pubmed:author | pubmed-author:DaganShlomoS | lld:pubmed |
pubmed-article:16772930 | pubmed:author | pubmed-author:BarneaYoavY | lld:pubmed |
pubmed-article:16772930 | pubmed:author | pubmed-author:Navon-Venezia... | lld:pubmed |
pubmed-article:16772930 | pubmed:author | pubmed-author:GurEyalE | lld:pubmed |
pubmed-article:16772930 | pubmed:author | pubmed-author:GatAndreaA | lld:pubmed |
pubmed-article:16772930 | pubmed:author | pubmed-author:NevilleLewis... | lld:pubmed |
pubmed-article:16772930 | pubmed:author | pubmed-author:KuzmenkoBoris... | lld:pubmed |
pubmed-article:16772930 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:16772930 | pubmed:volume | 117 | lld:pubmed |
pubmed-article:16772930 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16772930 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16772930 | pubmed:pagination | 2284-91 | lld:pubmed |
pubmed-article:16772930 | pubmed:dateRevised | 2011-2-16 | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:meshHeading | pubmed-meshheading:16772930... | lld:pubmed |
pubmed-article:16772930 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16772930 | pubmed:articleTitle | Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model. | lld:pubmed |
pubmed-article:16772930 | pubmed:affiliation | Department of Plastic and Reconstructive Surgery, Division of Epidemiology and Laboratory for Molecular Epidemiology and Antimicrobials Research, Pathology Institute, Tel-Aviv Sourasky Medical Center, Tel Aviv 64239, Israel. barneay@netvision.net.il | lld:pubmed |
pubmed-article:16772930 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16772930 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16772930 | lld:pubmed |